Stefanini Group, a $1 billion global technology company specializing in life science digital solutions that has its North American headquarters in Southfield, on Tuesday launched the Trust platform to improve clinical trials.
Formed in partnership with CliniOps, the platform helps digitize and automate trials from the study building phase to support decentralized, virtual, and hybrid trial capabilities.
Powered by Stefanini’s AI virtual assistant, Sophie, the platform automates processes resulting in significant time and cost reduction, and ultimately faster trials. Sophie can act as help desk support and study manager, answer clinician queries and questions, gather information from social listening, and retrieve documents to assist users across the function.
In addition, Sophie can be integrated with internal and external sources such as PubMed, clinicaltrial.gov, and other custom public data sources.
“Our goal at Stefanini Group is to use the latest digital technologies to transform life science business functions,” says Renata Galle, vice president of innovation and digital business at Stefanini Group. “Our Trust platform unifies the trial process, eliminating multiple vendors and high costs to increase efficiency and improve ROI.”
The Trust platform is built on Stefanini Life Science unit’s 20 years of experience supporting large and mid-size clients globally in clinical services. The unified platform consists of e-clinical solutions from study startup to conclusion like study builder, provisioning services, smart, and virtual trials. With a digital design, the platform integrates with all other third-party systems, devices, and applications currently being used in clinical trials for increased collaboration and faster results.
“A true one-of-a-kind in the market, the Trust platform provides customers with the opportunity to impact more patients,” says Nagesh Jadhav, director of digital transformation and innovation at Stefanini Life Sciences. “With digital and e-clinical solutions, the platform will be a game changer with increased transparency, insights, visibility, and audit readiness, ultimately resulting in faster trials.”
Founded in 2013, CliniOps is a data science for life science company that supports digital trials leveraging AI, mobile, analytics, cloud, sensors, and connected devices. CliniOps is headquartered in Fremont, Calif., with offices in India.
“The outbreak of a global pandemic has put many trials on hold and accelerated the need for digital and remote data capabilities,” says Avik Pal, CEO at CliniOps. “New processes need to be adapted to restart trials and transform them moving forward. CliniOps is very excited to partner with Stefanini, to address these challenges and bring an efficient solution to our valued customers.”
Stefanini Group offers organizations a broad portfolio of digital transformation services and solutions, including industrial automation, cognitive computing, workplace of the future development, customer experience, business consulting, digital marketing, and AI.
Stefanini Group is a Brazilian multinational company with more than 30 years of experience in the market, investing in a complete innovation ecosystem to meet the main verticals and assist customers in the process of digital transformation. The company utilizes automation, cloud, Internet of Things (IoT), and user experience (UX).
Stefanini’s Life Science unit supports several large and mid-sized pharmaceutical clients globally for device and hardware provisioning, technology for clinical trials, digital and marketing.
